Crawford, Nigel_resized

A/Prof Nigel Crawford

Chairman, ATAGI; Infectious Disease Specialist; Director, Surveillance of Adverse Events Following Vaccination In the Community (SAEFVIC), Murdoch Children’s Research Institute; Head of Immunisation Services Royal Children’s Hospital, Melbourne; Secondment Senior Medical Advisor, Victorian Department Health COVID19 vaccine safety team; Chair, Victorian Specialist Immunisation Services (VicSIS) network
Associate Professor Crawford is Director of SAEFVIC (Surveillance of Adverse Events Following Vaccination in the Community), a vaccine safety and clinical immunisation research group based at Murdoch Childrens Research Institute. Having completed his medical undergraduate studies at Flinders University Adelaide, A/Prof Crawford has a masters of public health from Cardiff University, Wales and a Vaccinology PhD from The University of Melbourne.

A/Prof Crawford is also the Head of the Immunisation Service at The Royal Children’s Hospital and an expert in the vaccination of special risk groups (e.g. immunosuppressed patients) and the clinical evaluation of adverse events following immunisation. He was the chief technical writer for the special risk section of the Australian Immunisation Handbook (NHMRC 2013) and was recently appointed to the Australian Technical and Advisory Group on Immunisation (ATAGI).

More from this expert

Practical understanding of the risk-benefit considerations as well as an update on AZ clots and bleeds.

Podcasts iconPodcasts

the recent developments in the management of the Australian pandemic including: An overview of the newly available Moderna vaccination; how the currently available vaccinations in Australia compare in terms of effectiveness against the Delta variant at preventing severe diseases as well as transmission

Podcasts iconPodcasts

A clinical overview of Novavax, is a fourth booster imminent for Australia? Post-COVID cardiovascular risk.

Podcasts iconPodcasts

The Omicron booster, latest ATAGI decisions including the Moderna baby dose and Novavax for teens. Plus the new variant vaccines, should we mix and match boosters?

Podcasts iconPodcasts

The national vaccine strategy and subdermal injection.

Podcasts iconPodcasts

Bivalent COVID-19 vaccine boosters - COVID-19 mAbs and anti-virals

Podcasts iconPodcasts

Booster confusion and are protein-based vaccines more likely to attract people?

Podcasts iconPodcasts